Form S-1/A Lakewood-Amedex Biothera
http://archive.fast-edgar.com/20260401/AE2ZPQ2CLW222Z5Z282P2ZY2BGVNZ222ZG82
Filed on: April 1, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genmab reports Phase 2 response rate data for petosemtamab in mCRC
- Takeda's TAK-921 meets dual endpoints in gastric cancer trial
- Citi reiterates Sell rating on Moderna with $80 price target
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share